Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Jul. 01, 2023
Jul. 02, 2022
Net sales $ 106,319 $ 126,875 $ 323,949 $ 369,319
Cost of goods sold 92,384 96,182 280,181 282,100
Gross profit 13,935 30,693 43,768 87,219
Selling, general and administrative expenses 18,491 22,416 56,658 59,613
Other (income), net (95) (1,018) (452) (1,947)
Operating (loss) income (4,461) 9,295 (12,438) 29,553
Interest expense, net 4,049 1,971 10,662 5,370
(Loss) earnings before (benefit from) provision for income taxes (8,510) 7,324 (23,100) 24,183
(Benefit from) provision for income taxes (2,218) 1,087 (6,214) 4,149
Consolidated net (loss) earnings (6,292) 6,237 (16,886) 20,034
Net (loss) income attributable to non-controlling interest (5) (3) (45) 11
Net (loss) earnings attributable to shareholders $ (6,287) $ 6,240 $ (16,841) $ 20,023
Basic (loss) earnings per share (in dollars per share) $ (0.90) $ 0.90 $ (2.41) $ 2.87
Diluted (loss) earnings per share (in dollars per share) $ (0.90) $ 0.88 $ (2.41) $ 2.84
Weighted average number of shares outstanding (in shares) 7,001 6,946 6,985 6,966
Dilutive effect of stock awards (in shares) 0 119 0 95
Weighted average number of shares assuming dilution (in shares) 7,001 7,065 6,985 7,061